Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

20. November 2009 02:07

Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time. [More]

2bb1b737-951a-4285-873c-0880246e1a8a|0|.0

Posted in: Pharmaceutical News

Tags: Cholesterol, Depression, Education, Hypothyroidism, Medicaid, Medicare, Prescription Drug

Wedgewood Pharmacy announces the compounding of thyroid tablets in response to physician demand

6. November 2009 03:09

Wedgewood Pharmacy announced today that it is compounding thyroid tablets in response to physician demand during the long-term backorder of Forest Laboratories’ Armour® Thyroid tablets. Compounded using Thyroid USP powder, a naturally occurring thyroid, Wedgewood Pharmacy’s scored tablets are available by prescription in 15mg, 30mg, 60mg and 120mg, with prices ranging from $21 to $25 per 100-count bottle. [More]

4c0797ae-b6a7-4d8d-b74c-152e331ee7a4|0|.0

Posted in: Pharmaceutical News

Tags: Hypothyroidism

Interim data from Schering-Plough's narlaprevir Phase IIa study

3. November 2009 03:02

Schering-Plough Corporation today reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1. [More]

1a7fbbff-144f-40e7-b2ff-2a96b6917170|1|5.0

Posted in: Drug Trial News | Disease/Infection News

Tags: Anemia, Angina, Angioedema, Anorexia, Anxiety, Arthritis, Blindness, Bone, Bone Marrow, Cancer, Cardiomyopathy, Cell, Cellulitis, Cirrhosis, Contraception, Creatinine, Depression, Dyspnea, Edema, Emphysema, Fibrosis, Gastroenteritis, Gout, Headache, Hepatitis C, Hepatology, Hyperglycemia, Hypersensitivity, Hyperthyroidism, Hypertriglyceridemia, Hypothyroidism, Insomnia, Liver Cancer, Lupus, Nausea, Neuropathy, Neutropenia, Pancreatitis, Peginterferon alfa, Pneumonia, Pregnancy, Psoriasis, Psychosis, Pulmonary Hypertension, Rheumatoid Arthritis, Ribavirin, Ritonavir, Sarcoidosis, Sepsis, Thalassemia, Thrombocytopenia, Thrombosis, Transient Ischemic Attack, Urticaria, Vasculitis, Virus, Vomiting, Weight Loss

Schering-Plough receives FDA complete response letter regarding PEGINTRON

31. October 2009 03:09

Schering-Plough Corp. announced today the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy. [More]

c3fa1d4f-06bd-4b30-80ad-b27272ea5cd9|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Anemia, Angina, Angioedema, Anorexia, Anxiety, Arthritis, Blindness, Bone, Bone Marrow, Cancer, Cardiomyopathy, Cell, Cellulitis, Cirrhosis, Contraception, Creatinine, Depression, Dyspnea, Edema, Emphysema, Fibrosis, Gastroenteritis, Gout, Headache, Hepatitis C, Hyperglycemia, Hypersensitivity, Hyperthyroidism, Hypertriglyceridemia, Hypothyroidism, Insomnia, Lupus, Melanoma, Nausea, Neuropathy, Neutropenia, Oncology, Pancreatitis, Pneumonia, Pregnancy, Psoriasis, Psychosis, Pulmonary Hypertension, Rheumatoid Arthritis, Ribavirin, Sarcoidosis, Sepsis, Thalassemia, Thrombocytopenia, Thrombosis, Transient Ischemic Attack, Urticaria, Vasculitis, Vomiting, Weight Loss

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

20. October 2009 05:40

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study. [More]

003e4c23-c045-4e9b-9be9-62e458918f8f|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Acetaminophen, Anemia, Biomarker, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Chromosome, Chronic Myeloid Leukemia, Congestive Heart Failure, Constipation, Contraception, Diarrhea, Edema, Erythromycin, Gleevec, Haloperidol, Headache, Heart Failure, Hematology, Hyperglycemia, Hyponatremia, Hypothyroidism, Imatinib Mesylate, Immunosuppression, Leukaemia, Leukemia, Leukopenia, Metabolism, Methadone, Myeloid Leukemia, Nausea, Neutropenia, Nursing, Oncology, Pancreatitis, Pathology, Pneumonia, Pregnancy, Thrombocytopenia, Vomiting, Warfarin

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

19. October 2009 08:38

Schering-Plough today announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Boston, Oct. 30-Nov. 3. [More]

5a662e81-818c-4eef-9ba6-1ed80bf43082|0|.0

Posted in: Drug Trial News | Disease/Infection News

Tags: Anemia, Angina, Angioedema, Anorexia, Anxiety, Arthritis, Blindness, Bone, Bone Marrow, Cancer, Cardiomyopathy, Cell, Cellulitis, Cholesterol, Cirrhosis, Contraception, Creatinine, Depression, Dyspnea, Edema, Emphysema, Fibrosis, Gastroenteritis, Gout, Headache, Hepatitis C, Hyperglycemia, Hypersensitivity, Hyperthyroidism, Hypertriglyceridemia, Hypothyroidism, Insomnia, Lipoprotein, Liver Cancer, Lupus, Nausea, Neuropathy, Neutropenia, Pancreatitis, Peginterferon alfa, Pneumonia, Pregnancy, Psoriasis, Psychosis, Pulmonary Hypertension, Rheumatoid Arthritis, Ribavirin, Sarcoidosis, Sepsis, Thalassemia, Thrombocytopenia, Thrombosis, Transient Ischemic Attack, Transplant, Urticaria, Vasculitis, Virus, Vomiting, Weight Loss

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

19. October 2009 07:40

AstraZeneca today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease. [More]

03cf77da-bfdf-412e-8622-1829f15af78a|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Atherosclerosis, Calcium, Cardiovascular Disease, Cholesterol, Cyclosporine, Diet, Dyslipidemia, Fibrates, Headache, Hypercholesterolemia, Hyperlipidemia, Hypersensitivity, Hypothyroidism, Lopinavir, Myopathy, Nausea, Neuroscience, New Drug Application, Nursing, Oncology, Pediatrics, Renal Failure, Ritonavir, Rosuvastatin, Statin

9% of Québec adults report being diagnosed with a thyroid disease

13. October 2009 04:36

New research reveals 9 percent of Québec adults report being diagnosed with a thyroid disease. The thyroid gland produces the hormones that regulate our growth, maturation, speed of metabolism and sensitivity to other hormones. [More]

4229c919-ee3b-457a-8be4-21251e61cd00|0|.0

Posted in: Medical Condition News

Tags: Depression, Hypothyroidism, Infertility, Metabolism, Osteoporosis

Schering-Plough receives FDA recommendation approval for PEGINTRON

6. October 2009 02:15

Schering-Plough Corp. announced today that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma. [More]

2c85957a-8af0-43ed-8612-5a44c9ace7bf|1|4.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anemia, Angina, Angioedema, Anorexia, Anxiety, Arthritis, Blindness, Bone, Bone Marrow, Cancer, Cardiomyopathy, Cell, Cellulitis, Cirrhosis, Contraception, Creatinine, Depression, Dyspnea, Edema, Emphysema, Fibrosis, Gastroenteritis, Gout, Headache, Hematology, Hepatitis C, Hyperglycemia, Hypersensitivity, Hyperthyroidism, Hypertriglyceridemia, Hypothyroidism, Insomnia, Lupus, Melanoma, Nausea, Neuropathy, Neutropenia, Oncology, Pancreatitis, Pneumonia, Pregnancy, Psoriasis, Psychosis, Pulmonary Hypertension, Rheumatoid Arthritis, Ribavirin, Sarcoidosis, Sepsis, Skin Cancer, Thalassemia, Thrombocytopenia, Thrombosis, Transient Ischemic Attack, Urticaria, Vasculitis, Vomiting, Weight Loss

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

21. September 2009 07:55

King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. [More]

6d1dd725-d612-496d-81a7-e164bbfd9b90|0|.0

Posted in: Pharmaceutical News

Tags: Addison's Disease, Alcohol Dependence, Analgesia, Anesthetics, Anxiety, Asthma, Blood Pressure, Constipation, Delirium, Depression, Diarrhea, Education, Head Injury, Hospital, Hypersensitivity, Hypothyroidism, Hypoxia, Morphine, Nausea, Nervous System, Neuroscience, Opioids, Osteoarthritis, Pancreatitis, Psychosis, Vomiting

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

21. September 2009 02:15

Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers. [More]

125df9a7-a355-4e9b-b393-aec88ac1a385|0|.0

Posted in: Medical Science News

Tags: Alopecia, Arrhythmia, Atrial Fibrillation, Baldness, Biopsy, Bone, Bone Marrow, Brain, Cancer, Cervical Cancer, Deep Brain Stimulation, Dwarfism, Education, Gene Therapy, Genetics, Hospital, Hypothyroidism, Neuroscience, Obesity, Parkinson's Disease, Penicillin, Pharmacology, Potassium, Potassium Channel, Pregnancy, Psychiatry

Forest Laboratories places Armour Thyroid medication on back order

15. September 2009 06:16

Forest Laboratories, Inc., the maker of the widely used hormone therapy drug, Armour® Thyroid, recently announced it has placed the medication on back order. The company said on its website that it does not have enough of the active ingredient, powdered Thyroid gland, in stock to produce the medication. [More]

e808519f-96a9-471c-ac9a-ef74fbe4a424|2|5.0

Posted in: Pharmaceutical News

Tags: Hypothyroidism

Giant pituitary adenoma can be safely removed through nasal route

12. August 2009 16:26

It’s even worse than being told you have a brain tumor: having a tumor so large, it’s in a category all its own. Giant pituitary adenoma is a so-called “benign” tumor that can cause visual loss and impair many of the body’s most basic functions. But fortunately, even the largest of these giant tumors—which can grow to the size of an egg and invade nearby structures--can be treated effectively using a multimodality approach starting with minimally invasive surgery through the nose, according to a new study at the John Wayne Cancer Institute at Saint John’s Health Center. [More]

f37526da-c0fa-4578-ac26-f4176e03c26f|0|.0

Posted in: Medical Procedure News | Medical Research News

Tags: Brain, Brain Tumor, Cancer, Colon Cancer, Education, Endocrinology, Growth Hormone, Hypothyroidism, Liver Cancer, Melanoma, Metabolism, Microscopy, Neurosurgery, Radiation Therapy, Skin Cancer, Spine, Stress, Trauma

Women with a history of hypothyroidism at greater risk of developing liver cancer

4. May 2009 21:31

Women with a history of hypothyroidism face a significantly higher risk of developing liver cancer, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience. [More]

c4e96027-0947-428a-8e20-c35f2ddbaf3d|0|.0

Posted in: Women's Health News

Tags: Cancer, Hepatitis B, Hepatitis C, Hepatocellular Carcinoma, Hepatology, Hyperlipidemia, Hypothyroidism, Insulin, Insulin Resistance, Liver Cancer, Obesity, Smoking, Smoking Addiction

Food giant Unilever on a worthy mission to reduce salt in all products

22. April 2009 03:44

The Anglo-Dutch food giant Unilever has announced plans to reduce the amount of salt in almost all its 22,000 food products - Unilever says its efforts to establish comprehensive salt reduction targets will help improve public health and are a first worldwide. [More]

c94af102-c016-4917-b804-522d0295aff1|0|.0

Posted in: Miscellaneous News

Tags: Blood Pressure, Cardiovascular Disease, Diet, Hypertension (High Blood Pressure), Hypothyroidism

Free!

Recent Comments

Twitter

Information

Hypothyroidism News and Research

Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients

Wedgewood Pharmacy announces the compounding of thyroid tablets in response to physician demand

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

AstraZeneca's CRESTOR approved for treating pediatric patients with HeFH

9% of Québec adults report being diagnosed with a thyroid disease

Schering-Plough receives FDA recommendation approval for PEGINTRON

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

Study reveals that KCNE2 and KCNQ1 mutations can results in thyroid dysfunction

Forest Laboratories places Armour Thyroid medication on back order

Giant pituitary adenoma can be safely removed through nasal route

Women with a history of hypothyroidism at greater risk of developing liver cancer

Food giant Unilever on a worthy mission to reduce salt in all products

Recent Articles

Free!

Recent Comments

Twitter

Information

Hypothyroidism News and Research

Medical News Cloud

Recent Articles